Literature DB >> 14769915

Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment.

Michael D Feese1, Taro Tamada, Yoichi Kato, Yoshitake Maeda, Masako Hirose, Yasuko Matsukura, Hideki Shigematsu, Takanori Muto, Atsushi Matsumoto, Hiroshi Watarai, Kinya Ogami, Tomoyuki Tahara, Takashi Kato, Hiroshi Miyazaki, Ryota Kuroki.   

Abstract

The cytokine thrombopoietin (TPO), the ligand for the hematopoietic receptor c-Mpl, acts as a primary regulator of megakaryocytopoiesis and platelet production. We have determined the crystal structure of the receptor-binding domain of human TPO (hTPO(163)) to a 2.5-A resolution by complexation with a neutralizing Fab fragment. The backbone structure of hTPO(163) has an antiparallel four-helix bundle fold. The neutralizing Fab mainly recognizes the C-D crossover loop containing the species invariant residue Q111. Titration calorimetric experiments show that hTPO(163) interacts with soluble c-Mpl containing the extracellular cytokine receptor homology domains with 1:2 stoichiometry with the binding constants of 3.3 x 10(9) M(-1) and 1.1 x 10(6) M(-1). The presence of the neutralizing Fab did not inhibit binding of hTPO(163) to soluble c-Mpl fragments, but the lower-affinity binding disappeared. Together with prior genetic data, these define the structure-function relationships in TPO and the activation scheme of c-Mpl.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769915      PMCID: PMC357010          DOI: 10.1073/pnas.0308530100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Rational design of potent antagonists to the human growth hormone receptor.

Authors:  G Fuh; B C Cunningham; R Fukunaga; S Nagata; D V Goeddel; J A Wells
Journal:  Science       Date:  1992-06-19       Impact factor: 47.728

2.  Efficiency of signalling through cytokine receptors depends critically on receptor orientation.

Authors:  R S Syed; S W Reid; C Li; J C Cheetham; K H Aoki; B Liu; H Zhan; T D Osslund; A J Chirino; J Zhang; J Finer-Moore; S Elliott; K Sitney; B A Katz; D J Matthews; J J Wendoloski; J Egrie; R M Stroud
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

3.  Mapping of the active site of recombinant human erythropoietin.

Authors:  S Elliott; T Lorenzini; D Chang; J Barzilay; E Delorme
Journal:  Blood       Date:  1997-01-15       Impact factor: 22.113

4.  Deletion of the extracellular membrane-distal cytokine receptor homology module of Mpl results in constitutive cell growth and loss of thrombopoietin binding.

Authors:  D F Sabath; K Kaushansky; V C Broudy
Journal:  Blood       Date:  1999-07-01       Impact factor: 22.113

5.  The glycan domain of thrombopoietin enhances its secretion.

Authors:  H M Linden; K Kaushansky
Journal:  Biochemistry       Date:  2000-03-21       Impact factor: 3.162

6.  Molecular cloning and chromosomal localization of the human thrombopoietin gene.

Authors:  Y Sohma; H Akahori; N Seki; T Hori; K Ogami; T Kato; Y Shimada; K Kawamura; H Miyazaki
Journal:  FEBS Lett       Date:  1994-10-10       Impact factor: 4.124

7.  A sequential dimerization mechanism for erythropoietin receptor activation.

Authors:  D J Matthews; R S Topping; R T Cass; L B Giebel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

8.  Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.

Authors:  I Matsumura; K Nakajima; H Wakao; S Hattori; K Hashimoto; H Sugahara; T Kato; H Miyazaki; T Hirano; Y Kanakura
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

9.  Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates.

Authors:  A M Farese; P Hunt; T Boone; T J MacVittie
Journal:  Blood       Date:  1995-07-01       Impact factor: 22.113

10.  Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation.

Authors:  A L Gurney; S C Wong; W J Henzel; F J de Sauvage
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

View more
  20 in total

1.  Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ.

Authors:  Luigi J Alvarado; Heather D Huntsman; Hai Cheng; Danielle M Townsley; Thomas Winkler; Xingmin Feng; Cynthia E Dunbar; Neal S Young; Andre Larochelle
Journal:  Blood       Date:  2019-02-25       Impact factor: 22.113

2.  A rationally designed agonist antibody fragment that functionally mimics thrombopoietin.

Authors:  Shana Frederickson; Mark W Renshaw; Bing Lin; Lynette M Smith; Peter Calveley; Jeremy P Springhorn; Krista Johnson; Yi Wang; Xiao Su; Yamin Shen; Katherine S Bowdish
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

3.  'Crystal lattice engineering,' an approach to engineer protein crystal contacts by creating intermolecular symmetry: crystallization and structure determination of a mutant human RNase 1 with a hydrophobic interface of leucines.

Authors:  Hidenori Yamada; Taro Tamada; Megumi Kosaka; Kohei Miyata; Shinya Fujiki; Masaru Tano; Masayuki Moriya; Mamoru Yamanishi; Eijiro Honjo; Hiroko Tada; Takeshi Ino; Hiroshi Yamaguchi; Junichiro Futami; Masaharu Seno; Takashi Nomoto; Tomoko Hirata; Motonobu Yoshimura; Ryota Kuroki
Journal:  Protein Sci       Date:  2007-07       Impact factor: 6.725

4.  Normal and pathological dynamics of platelets in humans.

Authors:  Gabriel P Langlois; Morgan Craig; Antony R Humphries; Michael C Mackey; Joseph M Mahaffy; Jacques Bélair; Thibault Moulin; Sean R Sinclair; Liangliang Wang
Journal:  J Math Biol       Date:  2017-04-08       Impact factor: 2.259

Review 5.  Biology and chemistry of thrombopoietic agents.

Authors:  David J Kuter
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

6.  Identification of the residues in the extracellular domain of thrombopoietin receptor involved in the binding of thrombopoietin and a nuclear distribution protein (human NUDC).

Authors:  Wei-Min Chen; Bo Yu; Qing Zhang; Peilin Xu
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

7.  An insight into the thermodynamic characteristics of human thrombopoietin complexation with TN1 antibody.

Authors:  Shigeki Arai; Chie Shibazaki; Motoyasu Adachi; Eijiro Honjo; Taro Tamada; Yoshitake Maeda; Tomoyuki Tahara; Takashi Kato; Hiroshi Miyazaki; Michael Blaber; Ryota Kuroki
Journal:  Protein Sci       Date:  2016-07-25       Impact factor: 6.725

8.  Dissection of vertebrate hematopoiesis using zebrafish thrombopoietin.

Authors:  Ondřej Svoboda; David L Stachura; Olga Machoňová; Petr Pajer; Jiří Brynda; Leonard I Zon; David Traver; Petr Bartůněk
Journal:  Blood       Date:  2014-05-28       Impact factor: 22.113

9.  Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.

Authors:  Jelena D Milosevic Feenstra; Harini Nivarthi; Heinz Gisslinger; Emilie Leroy; Elisa Rumi; Ilyas Chachoua; Klaudia Bagienski; Blanka Kubesova; Daniela Pietra; Bettina Gisslinger; Chiara Milanesi; Roland Jäger; Doris Chen; Tiina Berg; Martin Schalling; Michael Schuster; Christoph Bock; Stefan N Constantinescu; Mario Cazzola; Robert Kralovics
Journal:  Blood       Date:  2015-09-30       Impact factor: 22.113

Review 10.  New thrombopoietic growth factors.

Authors:  David J Kuter
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.